MOREPENLAB — Morepen Laboratories Cashflow Statement
0.000.00%
- IN₹34.00bn
- IN₹32.65bn
- IN₹16.90bn
- 65
- 31
- 48
- 46
Annual cashflow statement for Morepen Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 391 | 985 | 1,267 | 558 | 1,354 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -2.79 | 16.8 | -81.8 | -0.257 | 7.28 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -647 | -796 | -2,064 | -1,748 | -962 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 110 | 508 | -578 | -912 | 734 |
Capital Expenditures | -171 | -404 | -674 | -460 | -813 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 46.1 | -300 | 357 | -5.37 | -19.6 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Cash from Investing Activities | -125 | -704 | -317 | -465 | -833 |
Financing Cash Flow Items | 39.6 | -0.548 | 98.3 | -2.04 | 13.7 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 54.9 | 473 | 639 | 1,435 | 52 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 40.4 | 277 | -256 | 58.6 | -47.2 |